Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (7): 736-738.DOI: 10.3969/j.issn.1673-8640.2020.07.024
Previous Articles Next Articles
Received:2020-01-03
Online:2020-07-30
Published:2020-08-04
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.07.024
| 组别 | 例数 | 生化 | 免疫 | 急性心肌损伤 |
|---|---|---|---|---|
| 观察组 | 50 | 102.62±14.50 | 216.78±20.21 | 44.38±8.12 |
| 对照组 | 50 | 201.60±19.53 | 275.79±25.26 | 73.58±10.19 |
| t值 | 28.774 | 12.899 | 15.847 | |
| P值 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | 生化 | 免疫 | 急性心肌损伤 |
|---|---|---|---|---|
| 观察组 | 50 | 102.62±14.50 | 216.78±20.21 | 44.38±8.12 |
| 对照组 | 50 | 201.60±19.53 | 275.79±25.26 | 73.58±10.19 |
| t值 | 28.774 | 12.899 | 15.847 | |
| P值 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | σ值 | 符合 | 不符合 | |||
|---|---|---|---|---|---|---|---|
| 例数 | 百分比/% | 例数 | 百分比/% | ||||
| 观察组 | 50 | 5.12 | 46 | 92.00 | 4 | 8.00 | |
| 对照组 | 50 | 3.78 | 34 | 68.00 | 16 | 32.00 | |
| χ2值 | 9.000 | ||||||
| P值 | 0.003 | ||||||
| 组别 | 例数 | σ值 | 符合 | 不符合 | |||
|---|---|---|---|---|---|---|---|
| 例数 | 百分比/% | 例数 | 百分比/% | ||||
| 观察组 | 50 | 5.12 | 46 | 92.00 | 4 | 8.00 | |
| 对照组 | 50 | 3.78 | 34 | 68.00 | 16 | 32.00 | |
| χ2值 | 9.000 | ||||||
| P值 | 0.003 | ||||||
| 组别 | 例数 | 平均等待时间/d | 复诊次数/次 |
|---|---|---|---|
| 观察组 | 50 | 1.01±0.28 | 1.39±0.45 |
| 对照组 | 50 | 1.79±0.34 | 2.64±0.72 |
| t值 | 12.522 | 10.410 | |
| P值 | 0.000 | 0.000 |
| 组别 | 例数 | 平均等待时间/d | 复诊次数/次 |
|---|---|---|---|
| 观察组 | 50 | 1.01±0.28 | 1.39±0.45 |
| 对照组 | 50 | 1.79±0.34 | 2.64±0.72 |
| t值 | 12.522 | 10.410 | |
| P值 | 0.000 | 0.000 |
| 组别 | 例数 | 非常满意 | 满意 | 不满意 |
|---|---|---|---|---|
| 观察组 | 50 | 29（58.00） | 20（40.00） | 1（2.00） |
| 对照组 | 50 | 22（44.00） | 16（32.00） | 12（24.00） |
| χ2值 | 8.306 | |||
| P值 | 0.004 | |||
| 组别 | 例数 | 非常满意 | 满意 | 不满意 |
|---|---|---|---|---|
| 观察组 | 50 | 29（58.00） | 20（40.00） | 1（2.00） |
| 对照组 | 50 | 22（44.00） | 16（32.00） | 12（24.00） |
| χ2值 | 8.306 | |||
| P值 | 0.004 | |||
| [1] | 龚辉,严惟力,陈利云,等. 精益六西格玛理论在临床医疗中的运用[J]. 中华全科医师杂志,2017,16(3):236-239. |
| [2] | 毛丽娜,何永玲,龚明广,等. 门急诊采血患者检验结果回报时间需求的质性研究[J]. 检验医学与临床,2017,14(15):2191-2193. |
| [3] | 潘小华,董安,张洁. 精益六西格玛提高手术室后勤管理效率研究[J]. 护士进修杂志,2018,33(12):1115-1117. |
| [4] | 王岩,杨品娜,洪燕英. 六西格玛理论应用于不同血细胞分析仪性能评价[J]. 标记免疫分析与临床,2019,26(3):533-536. |
| [5] | 陆颖. 六西格玛管理法在分娩室护理管理中的应用评价[J]. 中国药物与临床,2019,19(12):2096-2097. |
| [6] | 李静,王静霞,孙宝苓,等. 医学实验室TAT运行管理探索[C]. 北京:2011. |
| [7] | 杨品娜,洪燕英. 应用六西格玛对实验室质量控制进行精准化管理[J]. 标记免疫分析与临床,2018,25(6):911-914. |
| [8] | WESTGARD S,BAYAT H,WESTGARD J O.Special issue on six sigma metrics-experiences and recommendations[J]. Biochem Med(Zagreb),2018,28(2):020301. |
| [9] | EVA N,VLADIMÍRA S,STEFAN K. Six sigma and dynamic models application as an important quality management tool in railway companies[J]. Proc Eng,2017,187(31):242-248. |
| [10] | 谢小娟,李小侠,孙晶晶,等. 应用六西格玛评价陕西省临床检验质量[J]. 中国卫生质量管理,2019,26(4):56-59. |
| [11] | 费惠,谢浩芬,朱红. 六西格玛管理法在减少日间手术接台延误中的应用效果[J]. 中华现代护理杂志,2018,24(15):1741-1744. |
| [12] | GUERRERO MONTERO I,RICHARDS K L,JAWARA C,et al.Escherichia coli 'TatExpress' strains export several g/L human growth hormone to the periplasm by the Tat pathway[J]. Biotechnol Bioeng,2019,116(12):3282-3291. |
| [13] | AVICAN U,DORUK T,ÖSTBERG Y,et al.The tat substrate sufi is critical for the ability of yersinia pseudotuberculosis to cause systemic infection[J]. Infect Immun,2017,85(4):e00807-16. |
| [14] | 李艳华,王岸,马晓菁,等. 基于FMEA的六西格玛在围术期医疗安全管理中的应用研究[J]. 山西医药杂志,2018,47(16):1963-1965. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
